Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fifteen years of continuous improvement of quality care of type 2 diabetes mellitus in primary care in Catalonia, Spain.
Mata-Cases M, Roura-Olmeda P, Berengué-Iglesias M, Birulés-Pons M, Mundet-Tuduri X, Franch-Nadal J, Benito-Badorrey B, Cano-Pérez JF; Diabetes Study Group in Primary Health Care (GEDAPS: Grup d’Estudi de la Diabetis a l’Atenció Primària de Salut, Catalonian Society of Family and Community Medicine). Mata-Cases M, et al. Int J Clin Pract. 2012 Mar;66(3):289-98. doi: 10.1111/j.1742-1241.2011.02872.x. Int J Clin Pract. 2012. PMID: 22340449 Free PMC article.
Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers.
Perea J, García JL, Corchete LA, Martí M, Hernández-Villafranca S, Alcázar JA, Álvaro E, Hurtado E, Jiménez-Toscano M, Balaguer F, Ballestero A, López-Rojo I, Jiménez F, Sanz G, Melone S, Brandáriz L, Vivas A, Alvarellos A, González-Sarmiento R; Spanish Early-Onset Colorectal Cancer Consortium (SECOC). Perea J, et al. Br J Surg. 2024 Mar 2;111(3):znae041. doi: 10.1093/bjs/znae041. Br J Surg. 2024. PMID: 38430195 No abstract available.
Unravelling heterogeneous effects of cancer‑associated fibroblasts on poor prognosis markers in breast cancer EM‑G3 cell line: In vitro‑targeted treatment (anti‑IL-6, anti‑VEGF-A, anti‑MFGE8) based on transcriptomic profiling.
Urban L, Novák Š, Čoma M, Dvořánková B, Lacina L, Šáchová J, Hradilová M, Svatoňová P, Kolář M, Strnad H, Březinová J, Smetana K Jr, Gál P, Szabo P. Urban L, et al. Among authors: coma m. Oncol Rep. 2024 Jan;51(1):3. doi: 10.3892/or.2023.8662. Epub 2023 Nov 17. Oncol Rep. 2024. PMID: 37975220 Free PMC article.
In silico evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression.
Gutiérrez-Casares JR, Segú-Vergés C, Sabate Chueca J, Pozo-Rubio T, Coma M, Montoto C, Quintero J. Gutiérrez-Casares JR, et al. Among authors: coma m. Front Neurosci. 2023 Jun 30;17:1118253. doi: 10.3389/fnins.2023.1118253. eCollection 2023. Front Neurosci. 2023. PMID: 37457000 Free PMC article.
In silico clinical trial evaluating lisdexamfetamine's and methylphenidate's mechanism of action computational models in an attention-deficit/hyperactivity disorder virtual patients' population.
Gutiérrez-Casares JR, Quintero J, Segú-Vergés C, Rodríguez Monterde P, Pozo-Rubio T, Coma M, Montoto C. Gutiérrez-Casares JR, et al. Among authors: coma m. Front Psychiatry. 2023 Jun 2;14:939650. doi: 10.3389/fpsyt.2023.939650. eCollection 2023. Front Psychiatry. 2023. PMID: 37333910 Free PMC article.
106 results